Lusine Yaghjyan University of Florida

Lusine Yaghjyan

Associate Professor

lyaghjyan@ufl.edu 352-294-5940
  • Gainesville FL UNITED STATES
  • College of Public Health and Health Professions

Lusine Yaghjyan's research focuses on the epidemiology of breast cancer.

Contact More Open options

Biography

Lusine Yaghjyan is an expert in cancer epidemiology, including cancer prevention and control, and environmental and molecular epidemiology. Her research focuses mostly on the epidemiology of breast cancer. She is an associate professor in the Department of Epidemiology in the College of Public Health and Health Professions.

Areas of Expertise

Epidemiology
Benign Breast Disease
Molecular Breast Cancer Epidemiology
Breast Cancer
Enviornmental Contributors to Breast Cancer Etiology
Cancer

Articles

Associations of coffee/caffeine consumption with postmenopausal breast cancer risk and their interactions with postmenopausal hormone use

European Journal of Nutrition

Lusine Yaghjyan, et al.

2022-05-18

We investigated the association of coffee and caffeine with breast cancer (BCa) risk, overall and by ER/PR status. We also examined potential interactions of coffee and caffeine with postmenopausal hormone use. Our study included 77,688 postmenopausal participants from the Women’s Health Initiative observational study cohort without a history of any cancer at baseline (except non-melanoma skin) and with valid Food Frequency Questionnaire data and complete data on dietary caffeine.

view more

Associations of established breast cancer risk factors with urinary estrogens in postmenopausal women

Cancer Causes and Control

Lusine Yaghjyan, et al.

2022-01-06

Circulating estrogens are an established risk factor for postmenopausal breast cancer (BCa). We describe the distribution of urinary estrogens, their metabolites, and relevant metabolic pathway ratios among healthy postmenopausal women and examine associations of several known BCa factors with these estrogen measures. Eligible postmenopausal women (n = 167) had no history of hormone use (previous 6 months) and cancer/metabolic disorders and had a body mass index (BMI) ≤ 35 kg/m2.

view more

Associations of Oral Contraceptives with Mammographic Breast Density in Premenopausal Women

Cancer Epidemiology, Biomarkers & Prevention

Lusine Yaghjyan, et al.

2021-12-03

We investigated the associations of oral contraceptives (OC) with percent breast density (PD), absolute dense area (DA), nondense area (NDA), and a novel image intensity variation (V) measure in premenopausal women. This study included 1,233 controls from a nested case-control study within Nurses' Health Study II cohort. Information on OCs was collected in 1989 and updated biennially. OC use was defined from the questionnaire closest to the mammogram date.

view more

Links

Powered By